Followers | 32 |
Posts | 2737 |
Boards Moderated | 0 |
Alias Born | 01/17/2014 |
Monday, May 15, 2017 3:59:24 PM
General and Administrative Expenses
Our general and administrative expenses were $281,331 for the three months ended March 31, 2017, as compared to $31,716 for the three months ended March 31, 2016. The approximate $250,000 increase included the additional costs of being a public company consisting of audit fees of $75,000, legal fees of $28,000, filing fees and outside services of $20,000. Additionally, our consultants fees to the CEO, CFO and other consultants increased $75,000. Other increases include website design of $6,000, insurance of $14,000, rent from adding a second office of $6,000, corporate secretary of $8,000, and various other administrative increases of $11,000.
I would think we could see the new companys new web-site along with the company name change to , "The Coretec Group Inc " and symbol change soon . The new company I believe will be very successful and I'm looking forward to hearing more from the new CEO who has been the CEO for about 6 weeks so I'm guessing we hear from him soon as well with insight on the company
business plan and goals moving forward under his new leadership.The best is yet to come!!
Recent CRTG News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 02:51:56 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/08/2023 06:06:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/31/2023 10:43:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/31/2023 10:41:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/31/2023 10:40:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/31/2023 10:38:33 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 10/31/2023 08:36:42 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 12:24:21 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM